BCM
LOXO

Bridgeway Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bridgeway Capital Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-30,250
Closed -$701K – 1508
2016
Q2 		$701K Buy
30,250
+50
+0.2% +$1.25K 0.01% 916
2016
Q1 		$826K Hold
30,200
– – 0.01% 847
2015
Q4 		$859K Buy
30,200
+200
+0.7% +$5.37K 0.02% 828
2015
Q3 		$524K Hold
30,000
– – 0.01% 1004
2015
Q2 		$541K Buy
+30,000
New +$410K 0.01% 1048

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridgeway Capital Management's LOXO Position: Q3 2016 in Review

Bridgeway Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q3 2016, closing a stake of 30,250 shares — an estimated $701K sold.

Bridgeway Capital Management first reported a position in LOXO in Q2 2015 and held it in 5 quarters. The position peaked at $859K in Q4 2015. 72 funds tracked by Wall St. Rank hold LOXO as of Q3 2016.

  • Bridgeway Capital Management reported no remaining Loxo Oncology, Inc position as of Q3 2016 after selling out during the quarter.
  • Bridgeway Capital Management sold 30,250 Loxo Oncology, Inc shares in Q3 2016, an estimated $701K.
  • Bridgeway Capital Management first reported a position in Loxo Oncology, Inc in Q2 2015 and held it in 5 quarters.
  • Bridgeway Capital Management's Loxo Oncology, Inc position peaked at $859K in Q4 2015.
  • 72 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2016.

Based on Bridgeway Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.